RETINAL VASCULITIS
Clinical trials for RETINAL VASCULITIS explained in plain language.
Never miss a new study
Get alerted when new RETINAL VASCULITIS trials appear
Sign up with your email to follow new studies for RETINAL VASCULITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Massive eye drug study reveals rare inflammation risk
Knowledge-focused CompletedThis study looked at over 550,000 people who received Eylea® injections for eye conditions to find out how often retinal vasculitis (a rare eye inflammation) occurs. Researchers used a large US registry and medical records to confirm cases. The goal was to better understand the s…
Matched conditions: RETINAL VASCULITIS
Sponsor: Regeneron Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Massive Real-World study investigates rare eye inflammation after common injection
Knowledge-focused CompletedThis completed study analyzed data from nearly 290,000 patients who received aflibercept (Eylea) injections for various retinal diseases. The goal was to estimate how often retinal vasculitis (inflammation of blood vessels in the eye) occurs in real-world clinical practice. Resea…
Matched conditions: RETINAL VASCULITIS
Sponsor: Regeneron Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC